Location History:
- Köln, DE (2006 - 2007)
- Cologne, DE (2022)
Company Filing History:
1 out of 12,160 
1 out of 201 
1 out of 21 
Years Active: 2006-2024
Title: Innovations by Markus Longerich: A Pioneer in Pharmaceutical Patent Development
Introduction
Markus Longerich, based in Cologne, Germany, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With a total of two patents to his name, Longerich has made significant strides in developing active compounds with enhanced properties, showcasing his expertise in innovative chemical formulations.
Latest Patents
Longerich's latest patents include a groundbreaking active compound product referred to as methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate. This invention presents improved properties such as better isolability, dischargeability after isolation and drying, as well as enhanced conveyability, sieveability, and micronizability. Additionally, he developed a method for the hydrolysis of quinolonecarboxylic esters, which enables the conversion of these esters into quinolonecarboxylic acids efficiently. This method includes specific reactant ratios using acetic acid, sulfuric acid, and water to optimize the hydrolysis process, particularly beneficial in synthesizing intermediates for pharmaceuticals such as pradofloxacin.
Career Highlights
Throughout his career, Markus Longerich has garnered extensive experience while working for prominent companies in the pharmaceutical industry, including Bayer Animal Health and Adverio Pharma. His work at these organizations has allowed him to refine his innovative abilities and contribute to the development of important pharmaceutical products.
Collaborations
In his professional journey, Longerich has collaborated with esteemed colleagues, such as Peter Fey and Mathias Berwe. These collaborations have not only enriched his research but also fostered innovation within the institutions they represented.
Conclusion
Markus Longerich stands out as an exemplary inventor in the pharmaceutical sector, making significant contributions through his patents and collaborative efforts. His work continues to pave the way for advancements in drug formulation and development, reinforcing the importance of innovation in improving health outcomes.